S&R Associates Represented Bertelsmann India Investments In USD 21 Million Series B Investment In CureBay Technologies

S&R Associates represented Bertelsmann India Investments in USD 21 Million Series B Investment in CureBay Technologies

S&R Associates represented Bertelsmann India Investments in its lead investment in CureBay Technologies, a technology-enabled hybrid healthcare platform, as part of a USD 21 million Series B funding round. The round also involved British International Investment and Elevar Equity.

The S&R Associates team was led by Rachael Israel (Partner) and Meher Mehta (Partner), with support from Aakriti Jalota (Associate), Advaita Kapoor (Associate), and Akanksha Agrahari (Associate).

Click to know more about S&R Associates

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.